{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:05:40Z","timestamp":1793235940965,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18411951000"],"award-info":[{"award-number":["18411951000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Multidrug resistant (MDR) and extensively drug resistant (XDR)\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      presents challenges for clinical treatment and causes high mortality in children. We aimed to assess the risk factors and overall mortality for MDR\/XDR\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      infected pediatric patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective study included 102 pediatric patients who developed MDR\/XDR\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      infection in the pediatric intensive care unit (PICU) of Shanghai Children\u2019s Hospital in China from December 2014 to May 2018.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      clinical isolates were recovered from different specimens including blood, sputum, bronchoalveolar lavage fluid, cerebrospinal fluid, ascites, hydrothorax, and urine. Antibiotic susceptibility test was determined according to the Clinical and Laboratory Standards Institute interpretive criteria. Clinical and biological data were obtained from the patients\u2019 medical records.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      102 patients with\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      infection were enrolled. The median age was 36 (9.6, 98.8) months, and there were 63 male in the case group. The overall mortality rate was 29.4%, while the\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      -associated mortality rate was 16.7% (17\/102, 12 bloodstream infections, 4 meningitis and 1 intra-abdominal infection). Bloodstream infections occurred in 28 patients (27.5%), and 10 patients (9.8%) among them had central line-associated bloodstream infections (6 central venous catheters, 2 PICCs, 1 venous infusion port and 1 arterial catheter). Cerebrospinal fluid (CSF) cultures were positive in 4(3.9%) patients. 14(13.7%) patients got positive cultures in ascites and hydrothorax. Lower respiratory isolates (56\/102) accounted for 54.9% of all patients. Non-survival patients appeared to have a lower NK cell activity (6.2%\u2009\u00b1\u20093.61% vs. 9.15%\u2009\u00b1\u20096.21%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.029), higher CD4+ T cell ratio (39.67%\u2009\u00b1\u200912.18% vs. 32.66%\u2009\u00b1\u200911.44%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.039),and a higher serum level of interlukin-8 (IL-8, 15.25 (1.62, 47.22)pg\/mL vs. 0.1 (0.1, 22.99)pg\/mL,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01) when\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      infection developed. Multivariate logistic analysis indicated that high serum level of Cr (RR, 0.934, 95%CI, 0.890\u20130.981;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007) and high BUN\/ALB level (RR, 107.893, 95%CI, 1.425\u2013870.574;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) were associated with high risk of mortality in MDR\/XDR\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      infected patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      MDR\/XDR\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      infection is a serious concern in pediatric patients with high mortality. Bloodstream and central nervous\u00a0system infection accounted for high risk of death. Acute kidney injury is associated with high risk of mortality.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05321-y","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T09:03:17Z","timestamp":1597222997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit"],"prefix":"10.1186","volume":"20","author":[{"given":"Jingyi","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-3600","authenticated-orcid":false,"given":"Yucai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"issue":"2","key":"5321_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijantimicag.2011.10.004","volume":"39","author":"M Kempf","year":"2012","unstructured":"Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012;39(2):105\u201314.","journal-title":"Int J Antimicrob Agents"},{"key":"5321_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5847\/wjem.j.issn.1920-8642.2012.03.008","volume":"3","author":"XF Cai","year":"2012","unstructured":"Cai XF, Sun JM, Bao LS, et al. Risk factors and antibiotic resistance of pneumonia caused by multidrug resistant Acinetobacter baumannii in pediatric intensive care unit. World J Emerg Med. 2012;3:202\u20137.","journal-title":"World J Emerg Med"},{"issue":"12","key":"5321_CR3","doi-asserted-by":"publisher","first-page":"O1028","DOI":"10.1111\/1469-0691.12716","volume":"20","author":"A Nutman","year":"2014","unstructured":"Nutman A, Glick R, Temkin E, et al. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia. Clin Microbiol Infect. 2014 Dec;20(12):O1028\u201334.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5321_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1099\/jmm.0.000421","volume":"66","author":"JA Karlowsky","year":"2017","unstructured":"Karlowsky JA, Hoban DJ, Hackel MA, et al. Antimicrobial susceptibility of gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-ABdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. J Med Microbiol. 2017 Jan;66(1):61\u20139.","journal-title":"J Med Microbiol"},{"issue":"3","key":"5321_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1089\/sur.2014.060","volume":"16","author":"MA Hackel","year":"2015","unstructured":"Hackel MA, Badal RE, Bouchillon SK, et al. Resistance rates of intra-ABdominal isolates from intensive care units and non-intensive care units in the United States: the study for monitoring antimicrobial resistance trends 2010-2012. Surg Infect. 2015 Jun;16(3):298\u2013304.","journal-title":"Surg Infect"},{"issue":"1","key":"5321_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2169\/internalmedicine.51.6018","volume":"51","author":"K Yamada","year":"2012","unstructured":"Yamada K, Yanagihara K, Araki N, et al. Clinical characteristics of tertiary hospital patients from whom Acinetobacter calcoaceticus-Acinetobacter baumannii Complex strains were isolated. Intern Med. 2012;51(1):51\u20137.","journal-title":"Intern Med"},{"issue":"4","key":"5321_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cmi.2015.12.010","volume":"22","author":"MP Freire","year":"2016","unstructured":"Freire MP, de Oliveira GD, Garcia CP, et al. Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia. Clin Microbiol Infect. 2016 Apr;22(4):352\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"5321_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1017\/ice.2018.58","volume":"39","author":"N Teerawattanapong","year":"2018","unstructured":"Teerawattanapong N, Panich P, Kulpokin D, et al. A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: the rise of multidrug-resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2018 May;39(5):525\u201333.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"5321_CR9","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1080\/22221751.2019.1698273","volume":"8","author":"O Ayobami","year":"2019","unstructured":"Ayobami O. Willrich N1, harder T, et al. the incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerg Microbes Infect. 2019;8(1):1747\u201359.","journal-title":"Emerg Microbes Infect"},{"key":"5321_CR10","first-page":"3150965","volume":"2018","author":"S Yang","year":"2018","unstructured":"Yang S, Sun J, Wu X, et al. Determinants of mortality in patients with nosocomial Acinetobacter baumannii bacteremia in Southwest China: a five-year case-control study. Can J Infect Dis Med Microbiol. 2018 Jun 3;2018:3150965.","journal-title":"Can J Infect Dis Med Microbiol."},{"key":"5321_CR11","doi-asserted-by":"crossref","unstructured":"Purdy J, Jouve S, Yan JL, et al. Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-lABel, ascending-dose study. Clin Ther. 2012 Feb;34(2):496\u2013507.e1.","DOI":"10.1016\/j.clinthera.2011.12.010"},{"issue":"6","key":"5321_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/INF.0000000000000699","volume":"34","author":"S Kanik-Yuksek","year":"2015","unstructured":"Kanik-Yuksek S, Tezer H, Ozkaya-Parlakay A, et al. Multidrug-resistant Acinetobacter baumannii bacteremia treated with tigecycline in two pediatric burn patients. Pediatr Infect Dis J. 2015 Jun;34(6):677.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"5321_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/ped.14133","volume":"62","author":"B Kim","year":"2020","unstructured":"Kim B, Kim K, Yoon JS. Nosocomial Acinetobacter baumannii infection in children in adult versus pediatric intensive care units. Pediatr Int. 2020 Apr;62(4):451\u20138.","journal-title":"Pediatr Int"},{"issue":"5","key":"5321_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jmii.2014.08.025","volume":"48","author":"HM Wei","year":"2015","unstructured":"Wei HM, Hsu YL, Lin HC, et al. Multidrug-resistant Acinetobacter baumannii infection among neonates in a neonatal intensive care unit at a medical center in Central Taiwan. J Microbiol Immunol Infect. 2015 Oct;48(5):531\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"5321_CR15","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1089\/mdr.2018.0465","volume":"25","author":"YJ Choe","year":"2019","unstructured":"Choe YJ, Lee HJ, Choi EH. Risk factors for mortality in children with Acinetobacter baumannii bacteremia in South Korea: the role of Carbapenem resistance. Microb Drug Resist. 2019 Oct;25(8):1210\u20138.","journal-title":"Microb Drug Resist"},{"issue":"5","key":"5321_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309\u201332.","journal-title":"Am J Infect Control"},{"issue":"3","key":"5321_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5321_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13054-018-1966-4","volume":"22","author":"KA Houston","year":"2018","unstructured":"Houston KA, George EC, Maitland K. Implications for paediatric shock management in resource-limited settings: a perspective from the FEAST trial. Crit Care. 2018;22(1):119.","journal-title":"Crit Care"},{"issue":"12","key":"5321_CR19","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.ajic.2019.07.009","volume":"47","author":"I Rossi","year":"2019","unstructured":"Rossi I, Royer S, Ferreira ML, et al. Incidence of infections caused by carbapenem-resistant Acinetobacter baumannii. Am J Infect Control. 2019 Dec;47(12):1431\u20135.","journal-title":"Am J Infect Control"},{"issue":"2","key":"5321_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1574-6976.2012.00344.x","volume":"37","author":"MJ McConnell","year":"2013","unstructured":"McConnell MJ, Actis L, Pachon J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 2013 Mar;37(2):130\u201355.","journal-title":"FEMS Microbiol Rev"},{"key":"5321_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538\u201382.","journal-title":"Clin Microbiol Rev"},{"key":"5321_CR22","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/AAC.48.5.1586-1592.2004","volume":"48","author":"PG Higgins","year":"2004","unstructured":"Higgins PG, Wisplinghoff H, Stefanik D. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2004;48:1586\u201392.","journal-title":"Antimicrob Agents Chemother"},{"key":"5321_CR23","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1128\/AAC.01230-13","volume":"57","author":"O Zusman","year":"2013","unstructured":"Zusman O, Avni T, Leibovici L, et al. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother. 2013;57:5104\u201311.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5321_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijantimicag.2014.10.002","volume":"45","author":"W Ni","year":"2015","unstructured":"Ni W, Shao X, Di X, et al. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Int J Antimicrob Agents. 2015 Jan;45(1):8\u201318.","journal-title":"Int J Antimicrob Agents"},{"key":"5321_CR25","doi-asserted-by":"crossref","unstructured":"Singkham-In U, Chatsuwan T. Singkham-In U. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates. Diagn Microbiol Infect Dis 2018;91:169\u2013174.","DOI":"10.1016\/j.diagmicrobio.2018.01.008"},{"issue":"6","key":"5321_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1189\/jlb.4AB0116-023RR","volume":"100","author":"G Kamoshida","year":"2016","unstructured":"Kamoshida G, Tansho-Nagakawa S, Kikuchi-Ueda T, et al. A novel bacterial transport mechanism of Acinetobacter baumannii via activated human neutrophils through interleukin-8. J Leukoc Biol. 2016 Dec;100(6):1405\u201312.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"5321_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013 Mar;13(3):159\u201375.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5321_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1164\/rccm.200505-730OC","volume":"173","author":"S Knapp","year":"2006","unstructured":"Knapp S, Wieland CW, Florquin S, Pantophlet R, Dijkshoorn L, Tshimbalanga N, et al. Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med. 2006 Jan 1;173(1):122\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"5321_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010033","volume":"5","author":"C March","year":"2010","unstructured":"March C, Regueiro V, Llobet E, et al. Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response. PLoS One. 2010 Apr 7;5(4):e10033.","journal-title":"PLoS One"},{"issue":"11","key":"5321_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005 Nov;6(11):1123\u201332.","journal-title":"Nat Immunol"},{"issue":"1","key":"5321_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcp.2007.02.012","volume":"74","author":"JS Lee","year":"2007","unstructured":"Lee JS, Lee JC, Lee CM, et al. Outer membrane protein a of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Biochem Pharmacol. 2007 Jun 30;74(1):86\u201397.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"5321_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/01.BCR.0000216291.68192.54","volume":"27","author":"M KAJr","year":"2006","unstructured":"KAJr M, Smith JW, Gamelli RL, et al. New perspectives for a new century: implications of pathogen responses for the future of antimicrobial therapy. J Burn Care Res. 2006 May-Jun;27(3):251\u201364.","journal-title":"J Burn Care Res"},{"key":"5321_CR33","doi-asserted-by":"publisher","first-page":"1547405","DOI":"10.1155\/2019\/1547405","volume":"2019","author":"DY Feng","year":"2019","unstructured":"Feng DY, Zhou YQ, Zou XL, et al. Elevated blood urea nitrogen-to-serum albumin ratio as a factor that negatively affects the mortality of patients with hospital-acquired pneumonia. Can J Infect Dis Med Microbiol. 2019;2019:1547405.","journal-title":"Can J Infect Dis Med Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05321-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T12:52:18Z","timestamp":1667739138000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5321"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05321-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.19520\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19520\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19520\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19520\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19520\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Ethics Review Committee, Children\u2019s Hospital of Shanghai\/Shanghai Children\u2019s Hospital, Shanghai Jiao Tong University and conducted in accordance with the provisions of the Declaration of Helsinki (Approval No.2016R011-F01). The data used in our study was anonymized before its use. All the data were obtained from the medical records of patients. All data generated or analyzed during this study are available from the corresponding author upon reasonable request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interests exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"597"}}